DK29491A - O-glycosyleret igf-1 - Google Patents

O-glycosyleret igf-1 Download PDF

Info

Publication number
DK29491A
DK29491A DK029491A DK29491A DK29491A DK 29491 A DK29491 A DK 29491A DK 029491 A DK029491 A DK 029491A DK 29491 A DK29491 A DK 29491A DK 29491 A DK29491 A DK 29491A
Authority
DK
Denmark
Prior art keywords
igf
glycosylated
glycosylated igf
expressed
obtaining
Prior art date
Application number
DK029491A
Other languages
English (en)
Other versions
DK175360B1 (da
DK29491D0 (da
Inventor
Anna Skottner-Lundin
Linda Fryklund
Paer Gellerfors
Original Assignee
Kabi Pharmacia Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kabi Pharmacia Ab filed Critical Kabi Pharmacia Ab
Publication of DK29491D0 publication Critical patent/DK29491D0/da
Publication of DK29491A publication Critical patent/DK29491A/da
Application granted granted Critical
Publication of DK175360B1 publication Critical patent/DK175360B1/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/80—Vectors or expression systems specially adapted for eukaryotic hosts for fungi
    • C12N15/81—Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/30—Insulin-like growth factors, i.e. somatomedins, e.g. IGF-1, IGF-2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/65—Insulin-like growth factors, i.e. somatomedins, e.g. IGF-1, IGF-2

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Diabetes (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Endocrinology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Wood Science & Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Mycology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Hematology (AREA)
  • Emergency Medicine (AREA)
  • Physics & Mathematics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Toxicology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Plant Pathology (AREA)
  • Obesity (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK199100294A 1988-08-20 1991-02-20 O-glycosyleret IGF-1 og farmaceutisk sammensætning indeholdende O-glycosyleret IGF-1 samt fremgangsmåder til fremstilling af begge DK175360B1 (da)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB8819826 1988-08-20
GB888819826A GB8819826D0 (en) 1988-08-20 1988-08-20 Glycosylated igf-1
EP8900972 1989-08-17
PCT/EP1989/000972 WO1990002198A1 (en) 1988-08-20 1989-08-17 O-glycosylated igf-1

Publications (3)

Publication Number Publication Date
DK29491D0 DK29491D0 (da) 1991-02-20
DK29491A true DK29491A (da) 1991-04-19
DK175360B1 DK175360B1 (da) 2004-09-13

Family

ID=10642464

Family Applications (1)

Application Number Title Priority Date Filing Date
DK199100294A DK175360B1 (da) 1988-08-20 1991-02-20 O-glycosyleret IGF-1 og farmaceutisk sammensætning indeholdende O-glycosyleret IGF-1 samt fremgangsmåder til fremstilling af begge

Country Status (15)

Country Link
US (1) US5273966A (da)
EP (2) EP0360411B1 (da)
JP (1) JP2543998B2 (da)
AT (1) ATE109206T1 (da)
AU (1) AU623675B2 (da)
CA (1) CA1335802C (da)
DE (1) DE68917061T2 (da)
DK (1) DK175360B1 (da)
ES (1) ES2060778T3 (da)
FI (1) FI102282B (da)
GB (1) GB8819826D0 (da)
IE (1) IE65096B1 (da)
NO (1) NO180636C (da)
NZ (1) NZ230383A (da)
WO (1) WO1990002198A1 (da)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8920381D0 (en) * 1989-09-08 1989-10-25 Greater Glasgow Health Board Treatment of insulin-resistant diabetes
US5612198A (en) * 1990-09-04 1997-03-18 The Salk Institute Production of insulin-like growth factor-1 in methylotrophic yeast cells
US5231178A (en) * 1991-01-16 1993-07-27 The Salk Institute Biotechnology/Industrial Associates, Inc. Method for the purification of intact, correctly-folded insulin-like growth factor-1
WO1992017595A1 (en) * 1991-04-01 1992-10-15 The Salk Institute Biotechnology/Industrial Associates, Inc. Genes which influence pichia proteolytic activity, and uses therefor
ES2097426T3 (es) * 1992-12-02 1997-04-01 Hoechst Ag Procedimiento para la obtencion de proinsulina con puentes de cistina correctamente unidos.
SE9402332D0 (sv) * 1994-07-01 1994-07-01 Pharmacia Ab Igf-1
US7833513B2 (en) 2004-12-03 2010-11-16 Rhode Island Hospital Treatment of Alzheimer's Disease
SI2032155T1 (sl) * 2006-06-09 2015-04-30 Novartis Ag Stabilizirani polipeptidi inzulinu podobnega rastnega faktorja
EP2494050A4 (en) * 2009-10-30 2013-10-30 Merck Sharp & Dohme FACTOR FOR STIMULATING GRANULOCYTES AND MONOCYTES PRODUCED IN GLYCOMODIFIED PICHIA PASTORIS
US20100172865A1 (en) * 2010-03-18 2010-07-08 Shantha Totada R Methods of enhancing hair growth
US9238080B2 (en) 2010-05-21 2016-01-19 Merrimack Pharmaceuticals, Inc. Bi-specific fusion proteins
CA2926173A1 (en) 2013-10-02 2015-04-09 Novartis Ag Insulin-like growth factor mimetics for use in therapy
WO2017059231A1 (en) 2015-10-02 2017-04-06 Silver Creek Pharmaceuticals, Inc. Bi-specific therapeutic proteins for tissue repair

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE95236T1 (de) * 1983-04-25 1993-10-15 Chiron Corp Hybrid-dns-synthesis von reifen insulinaehnlichen wachstumsfaktoren.

Also Published As

Publication number Publication date
EP0360411A1 (en) 1990-03-28
JPH05505514A (ja) 1993-08-19
GB8819826D0 (en) 1988-09-21
FI102282B1 (fi) 1998-11-13
FI910795A0 (fi) 1991-02-19
FI102282B (fi) 1998-11-13
DK175360B1 (da) 2004-09-13
EP0360411B1 (en) 1994-07-27
NO180636C (no) 1997-05-21
DE68917061T2 (de) 1994-11-17
NO910669D0 (no) 1991-02-19
NO180636B (no) 1997-02-10
DK29491D0 (da) 1991-02-20
AU4051889A (en) 1990-03-23
US5273966A (en) 1993-12-28
ATE109206T1 (de) 1994-08-15
ES2060778T3 (es) 1994-12-01
CA1335802C (en) 1995-06-06
IE892652L (en) 1990-02-20
NZ230383A (en) 1992-01-29
EP0429502A1 (en) 1991-06-05
AU623675B2 (en) 1992-05-21
WO1990002198A1 (en) 1990-03-08
DE68917061D1 (de) 1994-09-01
NO910669L (no) 1991-02-19
JP2543998B2 (ja) 1996-10-16
IE65096B1 (en) 1995-10-04

Similar Documents

Publication Publication Date Title
DE69034091D1 (de) Herstellung von Hämoglobin und Analogen davon in Nicht-Erythrozytzellen
ATE122357T1 (de) Polypeptide mit hormonwachstumsbefreiender wirkung.
FI851336A0 (fi) Ny fysiologiskt aktiv human polypeptid.
ES2153444T3 (es) Anticuerpos contra interleucina-4 mamifera, y peptidos utiles como antigenos en su produccion.
ATE107513T1 (de) Stabilisierte formulierungen mit hydrohoben proteinen.
ATE109206T1 (de) O-glycosylierter igf-1.
AU7184487A (en) Human g-csf protein expression
ATE358176T1 (de) Menschliche dnase
DE3689246D1 (de) Physiologisch aktives Polypeptid BUF-3.
DK0454898T3 (da) Glycosaminoglycan-modificeret protein, fremgangsmåde til fremstilling af proteinet, farmaceutiske præparater indeholdende proteinet samt anvendelse af proteinet
IT1232827B (it) Proteine biologicamente attive, formulazioni che le contengono e metodo per prepararle ed applicarle
ATE96671T1 (de) Verwendung von tetrahydrocortisol in der therapie von glaukom.
DE3650790D1 (de) Menschlisches Interferon-Beta 2A zur Verwendung als Arzneimittel
ATE73462T1 (de) Hirudin-variante, deren verwendung und herstellung.
AU3902489A (en) Non-glycosylated, recombinant human IL2 in the reduced form, the process for obtaining it and its use as a medicament
AU3327789A (en) Expression of the hiv 24 kda 24 gag protein in methylotrophic yeast
SE8802685D0 (sv) Stol
ATE98217T1 (de) Terpen-amino-alkohole und deren medizinische verwendung.
IE891349L (en) EXPRESSION OF THE HIV kDa GAG PROTEIN IN YEAST

Legal Events

Date Code Title Description
PBP Patent lapsed

Country of ref document: DK